PSZ
- Product code
- PSZ
- Device name
- Devices Detecting Influenza A, B, And C Virus Antigens
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3328
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 4
- Summaries archived here
- 4 (direct download)
- 510(k) clearances (all years, FDA)
- 72 (all years; only the last 3 years are listed here)
FDA classification definition
An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.
510(k) clearances, last 3 years (4)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K252283 | 2026-01-15 | Nano-Ditech Corporation | Nano-Check Influenza A+B Test | |
| K250398 | 2025-07-03 | Innovita (Tangshan) Biological Technol… | Innovita Flu A/B Antigen Rapid Test | |
| K241188 | 2025-04-18 | SEKISUI Diagnostics, LLC | Acucy® Influenza A&B Test with the Acucy® 2 System | |
| K232434 | 2023-12-05 | Bd | BD Veritor System for Rapid Detection of Flu A+B CL… |
Official FDA classification page: PSZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).